13F Holdings
中文EN

AORT ARTIVION, INC.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 784199 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.0%
TTM net income YoY-92.5%
TTM EPS YoY-56.5%
Revenue 3-yr CAGR12.4%
Net income 3-yr CAGR—

Margins

Gross margin63.3%
Operating margin2.3%
Net margin-3.7%
FCF margin-9.2%
EBITDA margin7.7%

Returns

ROE-4.0%
ROA-1.9%
ROIC (approx.)1.3%
Asset turnover0.51x

Leverage & solvency

Liabilities / assets57.2%
Debt / equity0.81x
Current ratio4.42x
Interest coverage0.41x

Cash quality & payout

Operating cash flow / net income-0.85x
Accruals ratio-3.4%
Payout ratio—
Capex / revenue12.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$441.33M$388.54M$354.00M$313.79M$298.84M
Cost of revenue$157.10M$139.76M$124.83M$111.27M$101.32M
Gross profit$284.23M$248.78M$229.18M$202.52M$197.51M
R&D expense$30.99M$28.45M$28.71M$38.88M$35.55M
SG&A expense$226.49M$181.46M$208.98M$157.44M$169.77M
Operating income$33.74M$38.87M$5.74M$6.20M$8.12M
Interest expense$26.58M$34.28M$25.30M$18.22M$16.89M
Pretax income$14.78M-$7.51M-$21.59M-$14.98M-$14.83M
Income tax$5.01M$5.84M$9.10M$4.21M$7,000
Net income$9.77M-$13.36M-$30.69M-$19.19M-$14.83M
EBITDA$56.20M$63.08M$28.82M$28.64M$32.09M
EPS (basic)0.22-0.32-0.75-0.48-0.38
EPS (diluted)0.21-0.32-0.75-0.48-0.38
Weighted avg. shares (diluted)47.16M41.68M40.74M40.03M38.98M
Balance sheet
Cash & equivalents$64.91M$53.46M$58.94M$39.35M$55.01M
Receivables$89.76M$79.46M$71.80M$61.82M$53.02M
Inventory$92.43M$79.77M$81.98M$74.48M$76.97M
Current assets$358.08M$290.08M$280.67M$247.33M$247.70M
PP&E, net$64.99M$36.40M$38.36M$38.67M$37.52M
Goodwill$254.09M$240.96M$247.34M$243.63M$250.00M
Intangibles$123.66M$128.05M$142.59M$151.26M$166.99M
Total assets$884.80M$789.10M$792.40M$762.80M$793.05M
Current liabilities$101.56M$66.82M$57.86M$49.67M$44.95M
Short-term debt$0$195,000$1.45M$1.61M$1.63M
Long-term debt$215.11M$314.15M$305.53M$306.50M$307.49M
Total debt$215.11M$314.35M$306.98M$308.11M$309.12M
Total liabilities$436.56M$512.90M$510.62M$478.47M$492.32M
Shareholders' equity$448.23M$276.20M$281.78M$284.33M$300.73M
Net debt$150.21M$260.88M$248.04M$268.76M$254.11M
Shares outstanding———41.83M—
Cash flow statement
Operating cash flow$39.88M$22.24M$18.82M-$5.15M-$2.58M
Capital expenditure$39.04M$11.19M$9.75M$10.71M$13.09M
Free cash flow$839,000$11.05M$9.07M-$15.87M-$15.68M
Investing cash flow-$42.04M-$28.19M-$502,000-$10.71M$5.66M
Financing cash flow$11.28M$2.20M$865,000-$1.64M-$12.22M
Depreciation & amortization$22.46M$24.20M$23.08M$22.44M$23.98M
Stock-based compensation$24.39M$14.24M$14.42M$12.34M$10.71M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.